Digital Look

Welcome to Digital Look++,
you are not logged in

Tissue Regenix Group (TRX)

Financials

0.000p

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-19	13.03	(7.66)	(60.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-20	16.47	(13.15)	(28.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	19.75	(5.14)	(7.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	24.48	(2.83)	(3.83)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	29.49	(1.67)	(2.43)¢	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Form 8.5 (EPT/NON-RI)- Tissue Regenix Group Plc	24-Apr-2025	09:38	RNS
Form 8.5 (EPT/NON-RI)	15-Apr-2025	09:23	RNS
Form 8.5 (EPT/NON-RI)	10-Apr-2025	09:09	RNS

Tissue Regenix flags first half in line with exp...	16-Jul-2024	ShareCast
Tissue Regenix purchases building at Texas site	14-Jun-2024	ShareCast
Tissue Regenix gets approval for Irish hub, inks...	30-Oct-2023	ShareCast

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.